Inventor profile of:

Wayne C. Widdison

City:

Belmont, Massachusetts

Country:

United States

Published Applications:

30

Last publication date:

2026-05-07

Top Assignees for applications by Wayne C. Widdison

The entities that hold a legal rights for patent applications filed by inventor Widdison Wayne C.:

Recent patent applications by Widdison Wayne C.

Wayne C. Widdison from Belmont, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-07
US20260124212A1
Human necessities

MAYTANSINOID DERIVATIVES WITH SELF-IMMOLATIVE PEPTIDE LINKERS AND CONJUGATES THEREOF

#2 | 2025-01-02
US20250007192A1
Electricity

METHODS FOR THE ACYLATION OF MAYTANSINOL

#3 | 2024-09-19
US20240313444A1
Electricity

METHODS FOR THE ACYLATION OF MAYTANSINOL

#4 | 2024-05-02
US20240145953A1
Electricity

METHODS FOR THE ACYLATION OF MAYTANSINOL

#5 | 2022-05-05
US20220133711A1
Human necessities

CAMPTOTHECIN DERIVATIVES

#6 | 2022-04-14
US20220111067A1
Human necessities

MAYTANSINOID DERIVATIVES WITH SELF-IMMOLATIVE PEPTIDE LINKERS AND CONJUGATES THEREOF

#7 | 2021-03-18
US20210077482A1
Human necessities

Camptothecin derivatives

#8 | 2020-06-25
US20200197531A1
Human necessities

Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof

#9 | 2020-05-14
US20200153130A1
Electricity

Methods for the acylation of maytansinol

#10 | 2020-05-14
US20200148764A1
Chemistry; metallurgy

Cross-linkers and their uses

#11 | 2019-01-10
US20190013604A1
Electricity

Methods for the acylation of maytansinol

#12 | 2018-10-18
US20180296694A1
Human necessities

Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof

#13 | 2018-10-11
US20180291100A1
Chemistry; metallurgy

Cross-linkers and their uses

#14 | 2018-04-12
US20180099980A1
Chemistry; metallurgy

Methods for the acylation of maytansinol

#15 | 2018-02-15
US20180043013A1
Human necessities

CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS (DM4)

#16 | 2017-06-08
US20170157264A1
Human necessities

CROSS-LINKERS AND THEIR USES

#17 | 2017-05-18
US20170137440A1
Chemistry; metallurgy

Methods for the acylation of maytansinol

#18 | 2016-09-15
US20160263238A1
Human necessities

Maytansinoid derivatives with peptide linker and conjugates thereof

#19 | 2016-05-19
US20160137604A1
Chemistry; metallurgy

Purification of intermediates used in the preparation of heterobifunctional linkers

#20 | 2016-03-03
US20160058882A1
Human necessities

CYTOTOXIC AGENTS COMPRISING NEW ANSAMITOCIN DERIVATIVES

#21 | 2015-12-17
US20150359904A1
Human necessities

Conjugates comprising cell-binding agents and cytotoxic agents

#22 | 2015-12-17
US20150359903A1
Human necessities

Conjugates comprising cell-binding agents and maytansinoids as cytotoxic agents

#23 | 2015-12-10
US20150352223A1
Human necessities

Cross-linkers and their uses

#24 | 2015-07-09
US20150191488A1
Chemistry; metallurgy

Methods for the acylation of maytansinol

#25 | 2015-03-12
US20150071949A1
Human necessities

CYTOTOXIC AGENTS COMPRISING NEW MAYTANSINOIDS (DM4)

#26 | 2014-06-26
US20140178416A1
Chemistry; metallurgy

Cross-linkers and their uses

#27 | 2014-05-22
US20140142297A1
Chemistry; metallurgy

Methods for the acylation of maytansinol

#28 | 2013-12-05
US20130323268A1
Human necessities

Cytotoxic agents comprising new ansamitocin derivatives

#29 | 2013-01-31
US20130029900A1
Chemistry; metallurgy

Maytansinoid derivatives with peptide linker and conjugates thereof

#30 | 2011-12-29
US20110319612A1
Chemistry; metallurgy

Elimination of heterogeneous or mixed cell population in tumors

InventorID:

68152 ⎘